These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15908969

  • 1. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y.
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [Abstract] [Full Text] [Related]

  • 2. Secondary solid tumors after allogeneic hematopoietic SCT in Japan.
    Yokota A, Ozawa S, Masanori T, Akiyama H, Ohshima K, Kanda Y, Takahashi S, Mori T, Nakaseko C, Onoda M, Kishi K, Doki N, Aotsuka N, Kanamori H, Maruta A, Sakamaki H, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).
    Bone Marrow Transplant; 2012 Jan; 47(1):95-100. PubMed ID: 21358690
    [Abstract] [Full Text] [Related]

  • 3. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G, Forrest DL.
    Cancer; 2007 Jan 01; 109(1):84-92. PubMed ID: 17131350
    [Abstract] [Full Text] [Related]

  • 4. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A.
    Oral Oncol; 2005 Oct 01; 41(9):865-77. PubMed ID: 16084755
    [Abstract] [Full Text] [Related]

  • 5. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.
    J Clin Oncol; 2007 Jun 10; 25(17):2449-54. PubMed ID: 17557958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y, Japan Marrow Donor Program.
    Br J Haematol; 2007 Apr 10; 137(2):142-51. PubMed ID: 17391494
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA.
    Bone Marrow Transplant; 2007 May 10; 39(9):555-61. PubMed ID: 17351645
    [Abstract] [Full Text] [Related]

  • 10. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC, Su SH, Laverdière M, Pépin J, Patiño C, Cohen S, Kiss T, Lachance S, Sauvageau G, Busque L, Roy DC, Roy J.
    Biol Blood Marrow Transplant; 2007 Oct 10; 13(10):1192-200. PubMed ID: 17889356
    [Abstract] [Full Text] [Related]

  • 11. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
    Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socié G.
    Cancer; 2008 Dec 15; 113(12):3315-22. PubMed ID: 18831513
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR.
    Biol Blood Marrow Transplant; 2005 Dec 15; 11(12):1014-21. PubMed ID: 16338624
    [Abstract] [Full Text] [Related]

  • 18. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
    Xu LP, Zhang HY, Huang XJ, Liu KY, Liu DH, Han W, Chen H, Chen YH, Gao ZY, Zhang YC, Lu DP.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1666-71. PubMed ID: 17935666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 05; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.